NAMI is helping bring clarity and safety to AI in mental health by evaluating chatbot responses, risks, and safeguards—guided by science and lived experience.
Analyzing several major pathology AI models designed to diagnose cancer, the researchers found unequal performance in ...
Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.
In a major milestone for Veeva AI, industry-specific AI for life sciences, Veeva Systems (NYSE: VEEV) today announced the ...
The FDA recently had a meeting to explore regulatory aspects of AI-enabled mental health medical devices. I explore a useful ...
The health care field agrees: artificial intelligence is already an integral tool being used every day in the industry. When ...
If 2024 was the year of proof-of-concept and 2025 was the year of early adoption and scale, 2026 is shaping up to be something different — a year defined by normalization. AI in healthcare won't fade ...
Detailed price information for Idexx Laboratories (IDXX-Q) from The Globe and Mail including charting and trades.
Discover 10 AI-proof healthcare careers that will remain secure as AI transforms helathcare, including roles that rely on ...
The IRBs are there for primarily federally funded research. But because this AI research is done with unconsented human data, ...
Learn how digital connectivity and the PathoVerse are improving pathology workflows and accelerating access to expert ...
NEXT reports the 11 fastest-growing small businesses for 2025, focusing on renewable energy, healthcare, and emerging tech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results